Pahr Therapeutics
Boston
About Pahr Therapeutics
Pahr Therapeutics is a clinical-stage business whose goal is to create innovative ways to treat pulmonary arterial hypertension.
Company Facts
- Operating status: Active
- IPO status: Private
- Total funding: $14.0M
- Funding stage: Seed
- Last round: Seed (Jul 2025)
- Website: pahrtx.com
- Phone: [email protected]
Industries & Categories
Clinical Trials
Canonical: https://fsome.com/organization/pahr-therapeutics-90751 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.